Supplementary Figure 3 from Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

Autor: Hagop M. Kantarjian, Elihu H. Estey, L. Austin Doyle, Steven M. Kornblau, Keith A. Baggerly, Wenbin Liu, Michael Andreeff, Jan A. Burger, LaKiesha Debose, Hongbo Lu, Jennie B. Feliu, Peter P. Ruvolo, Tapan M. Kadia, Xuelin Huang, Gautam Borthakur, Zhihong Zeng, Elias J. Jabbour, Stefan H. Faderl, Roland B. Walter, Marina Y. Konopleva
Rok vydání: 2023
DOI: 10.1158/1078-0432.22450359
Popis: PDF file - 50KB, Correlation between RPPA and immunoblotting in samples from the patients treated on MK-2206 trial.
Databáze: OpenAIRE